Advanced Search

Study Preview



Study Title and Description

The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.



Key Questions Addressed
9 Key Question 9. What is the association between experiencing SVR following antiviral treatment and reduction in risk of HCV-related adverse health outcomes?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
Author Dohmen K., Kawano A., Takahashi K., Shigematsu H., Tanaka H., Haruno M., Yanagita K., Ichiki Y., Mori T., Hayashida K., Shimoda S., Ishibashi H., Nomura H.
Country -- Not Found --
Year -- Not Found --
Numbers Pubmed ID: 24719946

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.